Siste oppdatering :
19/11/2024
InfoStab
Infostab
Lister
Lister
Sammendrag
Sammendrag
Søk etter kompatibilitet
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Y-side kompatibilitetstabell
Referanser
Referanser
Forskerteamet
Forskerteamet
valistab
valistab
plakat
plakat
Tilkoblinger
Tilkoblinger
sponsorer
sponsorer
Forfatter
Forfatter
Instruksjon
Instruksjon
Nyhetsbrev
Nyhetsbrev
Cytoprotektiva   Levofolinate calcium  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent
Calc Levof Italia
Calcium levofolinat Østerrike
Elvorine Belgia, Frankrike, Luxembourg, Marokko
Folaxin Spania
Folinate EG Belgia
Isovorin Danmark, Finland, Hellas, Island, Spania, Storbritannia, Sverige, Østerrike
Levofolatino de calcio Portugal
Levofolene Italia
Referanser   Injeksjon   Referanser : Levofolinate calcium  
Type publikasjon
3 Journal Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155 Journal Trissel LA, Martinez JF, Xu QA.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520 Labratorium Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1914 Labratorium Pemetrexed (Alimta®) - Summary of Product Characteristics
Eli Lilly 2016
2130 Journal Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Bull Cancer 1999 ; 86, 11: 946-954.
2181 Journal Milano G, Renée N.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Bull Cancer 1995 ; 82: 189-195.
2295 Labratorium Fosaprepitant (Emend®) - Summary of Product Characteristics
Merck Sharp Dohme 2013
2361 Journal Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531 Journal Sanogo S, Silimbani P, Gaggeri R, Masini C.
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369 Labratorium Levofolinate de sodium Medac - Résumé des caractéristiques du produits
MEDAC France 2011
3523 Labratorium Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3546 Labratorium Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3619 Labratorium Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
Wockhardt 2016
3621 Labratorium Phosphate dipotassique - Résumé des caractéristiques du produit
Renaudin 2008
3662 Labratorium Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3753 Labratorium Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
Cubist Pharmaceuticals 2014
3838 Labratorium Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3933 Labratorium Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
Teva Laboratoire 2015
4154 Labratorium Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4720 Labratorium Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
Paratek Pharmaceuticals 2021
  Mentions Légales